fluoro quinolones (test 3)

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/16

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

17 Terms

1
New cards

what are quinolones?

large group of broad spectrum bactericidal agents that share a bicyclic core structure related to the synthetic substance 4-quinolone

2
New cards

what is one all quinolones?

4-quinolone

3
New cards

name some quinolones

  • ciprofloxacin (IV, oral)

  • levofloxacin (IV, oral)

  • moxifloxacin (IV, oral)

  • delafloxacin (IV, oral)

4
New cards

fluoro quinolones

MOA:

  • inhibit bacterial ____ ____ ___ and ____ ____

  • inhibit DNA replication — how?

  • antibacterial activity is dependent on what?

  • DNA topoisomerase IV and DNA gyrase (topoisomerase II)

  • by disrupting the normal coiling/relaxing system of DS DNA

  • on concentration

5
New cards

fluoro quinolones

spectrum:

  • broad spectrum of activity: ????????????

gram -, gram +, atypical pathogens

6
New cards

fluoro quinolones

structure activity relationship:

  • DNA and DNA gryase binding

  • substitution _____ spectrum

  • _____ overall antimicrobial activity

  • what does fluorine substitution do?

  • increases

  • increases

  • increases membrane penetration (increases potency by 100 fold)

7
New cards

fluoro quinolones

toxicity (side effects):

  • ______ — tendon inflammation and/or rupture (often achilles tendon, 15-30% of cases)

  • ______ toxicity and _____ swelling in children

    • what should be avoided?

  • _____ ____ — can last month to years after discontinuation and may be permanent → discontinue immediately if symptoms occur

  • tendinopathy

  • cartilage; joint

    • pregnancy and breastfeeding

  • peripheral neuropathy

8
New cards

fluoro quinolones

toxicity (side effects):

  • ____ ____ — lightheadedness, dizziness, headache, sleeplessness, tiredness, abnormal vision, confusion (rare = psychosis, hallucinations, depression, seizures)

  • alters ____ ____ levels — hypoglycemia (can lead to coma) and hyperglycemia

  • ________, hepatoxicity, and crystalluria (must stay hydrated)

  • what are some common side effects?

  • CNS (neurotoxicity) effects

  • blood sugar

  • photosensitivity

  • N, D, dizziness, skin reactions

9
New cards

fluoro quinolones

resistance:

  • ______ in DNA gyrase (some gram +) and in topoisomerase IV (several gram +)

  • multidrug resistance ____ ____ expression in gram +

  • alterations in gram - membrane proteins — what does this lead to?

  • mutagenesis

  • efflux pump

  • changes in permeability and decreased uptake

10
New cards

fluoro quinolones

DDIs:

  • increase prothrombin time of _____ _____ leading to bleeding

  • _____ and _____ ____ (magnesium, aluminum, phosphate, calcium, iron, zinc), ______, and _____ ____ sequestrants can chelate and inhibit quinolone absorption

  • ______ binders (lanthanum carbonate) and sevelamer can decrease serum concentration of oral quinolones — separate administration is recommended

  • ______ can increase CNS complications (confusion, seizures)

  • anticoagulant warfarin

  • antacids and polyvalent cations, multivitamins and bile acid

  • phosphate

  • NSAIDs

11
New cards

fluoro quinolones

ciprofloxacin (cipro):

  • IV, oral, ophthalmic solution, ointments (tab/susp/injection)

  • ____ gen quinolone

  • WHO’s list of essential medicines

  • critically important for human medicine

  • one of the most commonly prescribed medications in the US

  • enhanced activity against _____ like Pseudomonas, Legionella, Mycoplasma pneumonia (1st line treatment)

  • used in a wide variety of infections including infections of bones and joints, endocarditis, gastroenteritis, malignant otitis externa, _____ _____ infections, cellulitis, UTI, prostatitis, anthrax, and chancroid

  • 2nd

  • gram -

  • respiratory tract

12
New cards

fluoro quinolones

levofloxacin:

  • IV, oral, ophthalmic solution (tab/susp/injection)

  • increased activity against _____ _____

  • _______ quinolone

  • _______ quinolone

  • 1st line treatment against Legionella pneumophila, Gonorrhea, and Penicillin-resistant S. pneumoniae

  • WHO’s List of Essential Medicines

  • used to treat several bacterial infections including acute bacterial sinusitis, pneumonia, ______ ______ (in combination with other medications), UTI, chronic prostatitis, and some types of gastroenteritis — along with other antibiotics it may be used to treat TB, meningitis, or pelvic inflammatory disease

  • streptococcus pneumoniae

  • respiratory

  • antipseudomonal

  • helicobacter pylori

13
New cards

fluoro quinolones

moxifloxacin:

  • ____ gen quinolone

  • IV, oral, ophthalmic solution (tab/susp/injection)

  • significant activity against ____ ____

  • ______ quinolone

  • good activity against what?

  • 1st line treatment for ______ _____ ____

  • used to treat several bacterial infections including respiratory-tract infections, cellulitis, anthrax, endocarditis, meningitis, intra-abdominal infections, conjunctivitis, tuberculosis, and sinusitis

  • because of enhanced gram + and anaerobic activity, can be used alone for _____ infections (intra abdominal infections)

  • only quinolone that CANNOT be used for what?

  • 4th

  • streptococcus pneumoniae

  • respiratory

  • gram +, gram -, anaerobes

  • penicillin resistant S. pneumoniae

  • polymicrobial

  • UTI

14
New cards

fluoro quinolones

delafloxacin:

  • ____ gen quinolone

  • IV (injection) and oral (tab)

  • active against straphylococcus aureus (______)

  • indicated to treat adults with acute ____ skin and skin _____ infections (ABSSSI)

  • preferred quinolone in _____ infections — other quinolones should be AVOIDED due to hgh rates of MRSA resistance

  • has increased potency and membrane permeability — why?

  • ____ spectrum of activity: Gm (+) S. aureus (MRSA), Staphylococcus haemolyticus, Staphylococcus lugdunensis, Streptococcus agalactiae, Streptococcus anginosus group (including Streptococcus anginosus, Streptococcus intermedius, and Streptococcus constellatus), Streptococcus pyogenes, and Enterococcus faecalis, Gm (-) Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, and Pseudomonas aeruginosa

  • active against other organisms such as _____ _____, Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus parainfluenzae, Chlamydia pneumoniae, Legionella pneumophila, and Mycoplasma pneumoniae

  • 4th

  • MRSA

  • bacterial; structure

  • skin

  • heavily fluorinated (and chlorinated)

  • large

  • streptococcus pneumoniae

15
New cards

cirpofloxacin structure

  • piperazine — increases _____ binding

  • both piperazine and cyclopropyl — increase ______ activity

  • gyrase

  • antibacterial

16
New cards

levofloxacin structure

  • methyl piperazine — _____ binding

  • L isomer of ofloxacin

  • extra ring increases _____ 2 fold and decreases ____ ____ ____ ____ ____

  • gyrase

  • potency

  • off target toxicity/side effects

17
New cards

moxifloxacin structure

  • increased _____ binding

    • double ring increases ______

  • cyclopropyl

  • both increase ______ activity

  • enabled activity against ______

  • gyrase

    • spectrum

  • antibacterial

  • anaerobes